Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

NVO

Novo Resources (NVO)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:NVO
DataOraFonteTitoloSimboloCompagnia
28/08/202318:14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NVO.WTTSX:NVONovo Resources Corp
28/08/202318:10PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NVO.WTTSX:NVONovo Resources Corp
05/02/202115:00PR Newswire (Canada)TMX Group Equity Financing Statistics - January 2021TSX:NVONovo Resources Corp
16/02/201014:00PR Newswire (US)Novo Nordisk Makes Victoza(R) Commercially Available in the United StatesNYSE:NVO
21/01/201021:49PR Newswire (US)Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'NYSE:NVO
14/01/201009:01PR Newswire (US)Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper DemonstratesNYSE:NVO
13/01/201015:43PR Newswire (US)/K I L L K I L L K I L L - National Changing Diabetes Program/NYSE:NVO
02/12/200915:00PR Newswire (US)FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to MenopauseNYSE:NVO
27/11/200915:30PR Newswire (US)Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study ShowsNYSE:NVO
19/11/200914:00PR Newswire (US)Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results ShowNYSE:NVO
30/10/200914:00PR Newswire (US)Novo Nordisk is Changing Possibilities in HemophiliaNYSE:NVO
20/10/200914:30PR Newswire (US)Data Analysis Reinforces the Safety Profile of Levemir(R)NYSE:NVO
01/09/200915:58PR Newswire (US)Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary DecisioNYSE:NVO
01/09/200914:00PR Newswire (US)National Changing Diabetes Program Supports Improvements in Health Cost EstimatesNYSE:NVO
27/08/200915:03PR Newswire (US)Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their FamiliesNYSE:NVO
12/08/200916:00PR Newswire (US)Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and DiabetesNYSE:NVO
10/08/200915:00PR Newswire (US)Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient ONYSE:NVO
05/08/200914:30PR Newswire (US)Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North AmericaNYSE:NVO
23/07/200915:00PR Newswire (US)NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and CareNYSE:NVO
15/07/200919:43PR Newswire (US)FDA Approves NovoLog(R) Labeling UpdateNYSE:NVO
13/07/200919:51PR Newswire (US)Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and TreatmentNYSE:NVO
28/06/200921:18PR Newswire (US)Novo Nordisk Insulin Analogs Have Proven Safety ProfilesNYSE:NVO
13/06/200919:09PR Newswire (US)Novo Nordisk Warns Customers About Stolen InsulinNYSE:NVO
12/06/200916:25PR Newswire (US)Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media SummitNYSE:NVO
08/06/200923:50PR Newswire (US)The Lancet Publishes Direct Comparison Study Between Liraglutide and ExenatideNYSE:NVO
08/06/200914:00PR Newswire (US)Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than GlimepirideNYSE:NVO
07/06/200916:00PR Newswire (US)Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162NYSE:NVO
20/05/200919:21PR Newswire (US)Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each YearNYSE:NVO
18/05/200913:00PR Newswire (US)Video: Academy Award(R) Winner Olympia Dukakis and Husband, Actor Louis Zorich, Encourage Older Adults to Ask.Screen.Know.NYSE:NVO
08/05/200915:14PR Newswire (US)Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) StuNYSE:NVO
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:NVO
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network